Icagen leads drug stock gains

Icagen leads drug stocks for the second day, climbing on speculation that it will soon be bought by industry heavyweight Pfizer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.